Porton Pharma Solutions (SZSE:300363) Forward Dividend Yield % : 3.20% (As of May. 28, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Porton Pharma Solutions Forward Dividend Yield %?

As of today (2024-05-28), the Forward Annual Dividend Yield of Porton Pharma Solutions is 3.20%.

As of today (2024-05-28), the Trailing Annual Dividend Yield of Porton Pharma Solutions is 7.29%.

SZSE:300363's Forward Dividend Yield % is ranked better than
74.49% of 486 companies
in the Drug Manufacturers industry
Industry Median: 1.875 vs SZSE:300363: 3.20

Porton Pharma Solutions's Dividends per Share for the three months ended in Mar. 2024 was ¥0.00.

During the past 12 months, Porton Pharma Solutions's average Dividends Per Share Growth Rate was 473.10% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 119.90% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 93.70% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Porton Pharma Solutions was 119.90% per year. The lowest was -5.70% per year. And the median was 33.90% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Porton Pharma Solutions's Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Porton Pharma Solutions's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Porton Pharma Solutions's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Porton Pharma Solutions's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Porton Pharma Solutions's Forward Dividend Yield % falls into.

Porton Pharma Solutions Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Porton Pharma Solutions (SZSE:300363) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Porton Pharma Solutions Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Porton Pharma Solutions's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Porton Pharma Solutions (SZSE:300363) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Porton Pharma Solutions Ltd (SZSE:300363) » Definitions » Forward Dividend Yield %

Traded in Other Exchanges

N/A

Address

Fangzheng Avenue, Porton New Drug Outsourcing Service and R&D Center, Shuitu, Beibei District, Chongqing, CHN, 400714

Website

http://www.porton.cn

Porton Pharma Solutions Ltd is a China-based external manufacturing supplier of custom drug intermediates and Active Pharmaceutical Ingredients (APIs) to pharmaceutical companies. It is engaged in the process development activities and pilot-scale and commercial-scale manufacturing activities.

Executives

Wang Zhong Neng	Executives
Yu Yong Mei	Executives
Sun Min	Executives
Ji Yao Hui	Executives
Ju Nian Feng	Directors, executives
Tan Jun	Supervisors
Xu Ai Wu	Directors, executives
Guo Yong Qing	Independent director
	Director
	Director
Ceng Hui	Supervisors
Chen Bei	Executives

Porton Pharma Solutions (SZSE:300363) Headlines

No Headlines